Targeting Aberrant Splicing in Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

Targeting Aberrant Splicing in Myelodysplastic Syndromes

Published:2020-04 Issue:2 Volume:34 Page:379-391
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Brunner Andrew M.,Steensma David P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference88 articles.

1. Myelodysplastic syndromes;Steensma;Mayo Clin Proc,2015

2. Recent advances in the cellular and molecular understanding of myelodysplastic syndromes: implications for new therapeutic approaches;Brunner;Clin Adv Hematol Oncol,2018

3. Clonal evolution in myelodysplastic syndromes;da Silva-Coelho;Nat Commun,2017

4. Risk and timing of cardiovascular death among patients with myelodysplastic syndromes;Brunner;Blood Adv,2017

5. Graphical representation of clinical outcomes for patients with myelodysplastic syndromes;Steensma;Leuk Lymphoma,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing in myelodysplastic syndromes;Diagnostic Molecular Pathology;2024

2. U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review);Oncology Reports;2023-11-16

3. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial;The Lancet;2023-07

4. Proteomic discovery of chemical probes that perturb protein complexes in human cells;Molecular Cell;2023-05

5. Identification of a novel alternatively spliced isoform of the ribosomal uL10 protein;Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms;2023-03